Validation of AI-ENDO System in Endoscopic Submucosal Dissection

Recruiting N/A Interventional Study
Superficial Esophageal, Gastric or Colorectal Lesions
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Chinese University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study is a pilot trial designed to evaluate the feasibility and safety of Al-ENDO assisted ESD in patients with gastrointestinal superficial lesions. Patients with gastrointestinal superficial lesions are scheduled for conventional ESD will be screened for eligibility. The study consists of a few stages: 1. In the first phase, the Al-ENDO system will be tested in the background of the ESD pr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient with superficial esophageal, gastric or colorectal lesions, scheduled for endoscopic submucosal dissection (ESD). * Age between 18 and 85. Exclusion Criteria: * Patient who refused to participate. * Other cases deemed by the examining physician as unsuitable for safe…
Contacts

Hon Chi Yip

+852 3505 2956

hcyip@surgery.cuhk.edu.hk

CONTACT